消化指南

订阅

MedSci主页 / 所有栏目 / 消化指南

2021 AGA临床实践指南：胃内气囊在肥胖管理中的应用

2021-04-10 美国胃肠病协会 Gastroenterology.2021 Apr;160(5):1799-1808

肥胖胃内气囊

2021年4月，美国胃肠病协会(AGA)发布了胃内气囊在肥胖管理中的应用指南。肥胖是一种全球性的流行病，在减重干预方面还有大量需求没有被满足。本文主要针对胃内气囊在肥胖管理中的应用提供指导建议。

中文标题：

2021 AGA临床实践指南：胃内气囊在肥胖管理中的应用

英文标题：

AGA Clinical Practice Guidelines on Intragastric Balloons in the Management of Obesity

发布机构：

美国胃肠病协会

发布日期：

2021-04-10

简要介绍：

2021年4月，美国胃肠病协会(AGA)发布了胃内气囊在肥胖管理中的应用指南。肥胖是一种全球性的流行病，在减重干预方面还有大量需求没有被满足。本文主要针对胃内气囊在肥胖管理中的应用提供指导建议。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 AGA临床实践指南：胃内气囊在肥胖管理中的应用.pdf)] GetToolGuiderByIdResponse(projectId=1, id=293c01c0020886f9, title=2021 AGA临床实践指南：胃内气囊在肥胖管理中的应用, enTitle=AGA Clinical Practice Guidelines on Intragastric Balloons in the Management of Obesity, guiderFrom=Gastroenterology.2021 Apr;160(5):1799-1808, authorId=0, author=, summary=2021年4月，美国胃肠病协会(AGA)发布了胃内气囊在肥胖管理中的应用指南。肥胖是一种全球性的流行病，在减重干预方面还有大量需求没有被满足。本文主要针对胃内气囊在肥胖管理中的应用提供指导建议。, cover=https://img.medsci.cn/2021425/1619364177148_2020535.jpg, journalId=0, articlesId=null, associationId=102, associationName=美国胃肠病协会, associationIntro=美国胃肠病协会成立于1897年,已包括来自全球各地17000个成员参与消化所有方面的研究、实践和前沿。提供各项关于胃肠道疾病的指南和研究，发布两本期刊，都为月刊，每年5月份会举行年会。, copyright=0, guiderPublishedTime=Sat Apr 10 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年4月，美国胃肠病协会(AGA)发布了胃内气囊在肥胖管理中的应用指南。肥胖是一种全球性的流行病，在减重干预方面还有大量需求没有被满足。本文主要针对胃内气囊在肥胖管理中的应用提供指导建议。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=332, tagName=肥胖), TagDto(tagId=111706, tagName=胃内气囊)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=332, guiderKeyword=肥胖, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5865, appHits=65, showAppHits=0, pcHits=346, showPcHits=5799, likes=2, shares=7, comments=9, approvalStatus=1, publishedTime=Sun Apr 25 23:33:40 CST 2021, publishedTimeString=2021-04-10, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun Apr 25 23:23:44 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 21:37:26 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 AGA临床实践指南：胃内气囊在肥胖管理中的应用.pdf)])
2021 AGA临床实践指南：胃内气囊在肥胖管理中的应用.pdf
下载请点击：
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=978853, encodeId=418d9e88533b, content=了解了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73835475130, createdName=我是谁是我, createdTime=Fri Jul 02 05:36:16 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976394, encodeId=ebff9e639414, content=好，非常感谢，不错。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4fcf1618035, createdName=jason0099, createdTime=Thu Jun 24 01:06:39 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965230, encodeId=ae6a96523080, content=好指南！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu May 13 16:00:54 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964043, encodeId=f89c96404301, content=好指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/23398bcfb6b04c079640e45ae40219be/ec04f3d9b76844a6b8e411eb10034b68.jpg, createdBy=c4751612771, createdName=matchabase, createdTime=Sun May 09 17:58:45 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964024, encodeId=e9a19640247b, content=好指南！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun May 09 17:47:23 CST 2021, time=2021-05-09, status=1, ipAttribution=)]
    2021-07-02 我是谁是我

    了解了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=978853, encodeId=418d9e88533b, content=了解了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73835475130, createdName=我是谁是我, createdTime=Fri Jul 02 05:36:16 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976394, encodeId=ebff9e639414, content=好，非常感谢，不错。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4fcf1618035, createdName=jason0099, createdTime=Thu Jun 24 01:06:39 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965230, encodeId=ae6a96523080, content=好指南！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu May 13 16:00:54 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964043, encodeId=f89c96404301, content=好指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/23398bcfb6b04c079640e45ae40219be/ec04f3d9b76844a6b8e411eb10034b68.jpg, createdBy=c4751612771, createdName=matchabase, createdTime=Sun May 09 17:58:45 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964024, encodeId=e9a19640247b, content=好指南！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun May 09 17:47:23 CST 2021, time=2021-05-09, status=1, ipAttribution=)]
    2021-06-24 jason0099

    好，非常感谢，不错。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=978853, encodeId=418d9e88533b, content=了解了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73835475130, createdName=我是谁是我, createdTime=Fri Jul 02 05:36:16 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976394, encodeId=ebff9e639414, content=好，非常感谢，不错。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4fcf1618035, createdName=jason0099, createdTime=Thu Jun 24 01:06:39 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965230, encodeId=ae6a96523080, content=好指南！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu May 13 16:00:54 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964043, encodeId=f89c96404301, content=好指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/23398bcfb6b04c079640e45ae40219be/ec04f3d9b76844a6b8e411eb10034b68.jpg, createdBy=c4751612771, createdName=matchabase, createdTime=Sun May 09 17:58:45 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964024, encodeId=e9a19640247b, content=好指南！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun May 09 17:47:23 CST 2021, time=2021-05-09, status=1, ipAttribution=)]
    2021-05-13 jyzxjiangqin

    好指南！

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=978853, encodeId=418d9e88533b, content=了解了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73835475130, createdName=我是谁是我, createdTime=Fri Jul 02 05:36:16 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976394, encodeId=ebff9e639414, content=好，非常感谢，不错。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4fcf1618035, createdName=jason0099, createdTime=Thu Jun 24 01:06:39 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965230, encodeId=ae6a96523080, content=好指南！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu May 13 16:00:54 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964043, encodeId=f89c96404301, content=好指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/23398bcfb6b04c079640e45ae40219be/ec04f3d9b76844a6b8e411eb10034b68.jpg, createdBy=c4751612771, createdName=matchabase, createdTime=Sun May 09 17:58:45 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964024, encodeId=e9a19640247b, content=好指南！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun May 09 17:47:23 CST 2021, time=2021-05-09, status=1, ipAttribution=)]
    2021-05-09 matchabase

    好指南

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=978853, encodeId=418d9e88533b, content=了解了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73835475130, createdName=我是谁是我, createdTime=Fri Jul 02 05:36:16 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976394, encodeId=ebff9e639414, content=好，非常感谢，不错。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4fcf1618035, createdName=jason0099, createdTime=Thu Jun 24 01:06:39 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965230, encodeId=ae6a96523080, content=好指南！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu May 13 16:00:54 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964043, encodeId=f89c96404301, content=好指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/23398bcfb6b04c079640e45ae40219be/ec04f3d9b76844a6b8e411eb10034b68.jpg, createdBy=c4751612771, createdName=matchabase, createdTime=Sun May 09 17:58:45 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964024, encodeId=e9a19640247b, content=好指南！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun May 09 17:47:23 CST 2021, time=2021-05-09, status=1, ipAttribution=)]
    2021-05-09 jyzxjiangqin

    好指南！

    0

相关指南

成人肥胖：临床实践指南2020

暂未更新 · 2020-09-03

FIGO怀孕与非传染性疾病委员会对孕前，妊娠和产后肥胖的管理：FIGO（国际妇产科联合会）指南

国际妇产科联盟(FIGO,International Federation of Gynecology and Obstetrics) · 2020-09-08

2020 加拿大临床实践指南：成人肥胖

国外内分泌相关专家小组（统称） · 2020-08-04

2020 FISPGHAN意见书：儿童时期肥胖的预防

国际儿童胃肠病学、肝病学和营养学会联盟(FISPGHAN,Federation of International Societies of Pediatric Gastroenterology, Hepatology, and Nutrition) · 2020-03-20

2020 ESE临床实践指南：肥胖的内分泌检查

欧洲内分泌学会(ESE,European Society of Endocrinology) · 2020-01-10

2016 ISTH指南：使用直接口服抗凝剂治疗肥胖患者

国际血栓与止血学会(ISTH,International Society on Thrombosis and Haemostasis) · 2016-04-27

拓展阅读

2011 IDF 减重手术治疗肥胖伴2型糖尿病的立场声明

国际糖尿病联盟(IDF,International Diabetes Federation) · 2011-03-03

2011CES 中国成人肥胖症防治专家共识

中华医学会内分泌学分会(CSE,Chinese Society of Endocrinology) · 2011-09-01

2012AHA关于父母行为改变策略与代沟研究证据的科学声明：父母和成人监护人作为&ldquo;变更代理人&rdquo;治疗儿童肥胖症的效果评估

美国心脏协会(AHA,American Heart Association) · 2012-01-23

ASCO指南：肥胖癌症患者合适的化疗剂量

美国临床肿瘤学会(ASCO,American Society of Clinical Oncology) · 2012-04-02

2012EASO/ESH 肥胖和难治性动脉高血压联合声明

欧洲肥胖症研究学会(EASO,European Association for the Study of Obesity) · 2012-06-05

2012 EASO指南：老年人肥胖的患病率、病理生理、健康后果和治疗选择

欧洲肥胖症研究学会(EASO,European Association for the Study of Obesity) · 2012-06-20